Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Dr. Carlos Nunez, chief medical officer, will present at the 44 th Annual J.P. Morgan Healthcare ...

If you are wondering whether ResMed is still attractive after its strong run, or if the market has already priced in the upside, this article will help you cut through the noise and focus on what the ...

SAN DIEGO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, today announced it has ...

Resmed (NYSE: RMD) announced today that it received FDA clearance for its Smart Comfort personalized therapy comfort settings ...

Resmed has received clearance from the U.S. Food and Drug Administration (FDA) for an artificial intelligence (AI)-enabled ...

Resmed believes its artificial intelligence-powered approach to personalizing the settings of its connected CPAP machines can lead to better sleep for people with obstructive apnea. | Resmed believes ...

Resmed gains FDA's nod for Smart Comfort, an AI-driven CPAP tool boosting sleep therapy personalization and adherence.

Using the 2 Stage Free Cash Flow to Equity, ResMed fair value estimate is US$257 ResMed's US$256 share price indicates it is trading at similar levels as its fair value estimate The US$293 analyst ...

Ashvin AI co-founder Mathew Mammen is leveraging decades of experience in DME and health tech to tackle one of the industry’s biggest challenges: growing demand but ...

Former Cochlear boss Catherine Livingstone sits on the board of the US-based company which lost more than 50 pct of its value ...

Pioneering the shift from bulky, short-term heart monitors to sleek, wire-free patches, iRhythm Technologies (NASDAQ:IRTC) ...

Cancer related cognitive impairment in patients can stem from the cancer itself as well as the therapies used to treat it.